Press releases

S-ICD System is world's first and only commercially available completely subcutaneous implantable defibrillator.

First and only commercially available DBS system to incorporate multiple independent current control, which is designed to selectively stimulate targeted areas in the brain.

Next-generation balloon catheter offers enhanced deliverability and expanded options for treating coronary artery lesions

RELIANCE® 4-FRONT™ lead designed to streamline surgical procedure for treatment of heart failure and sudden cardiac arrest.

Company to acquire innovative, minimally invasive technologies for the treatment of coronary chronic total occlusions.

New bronchial thermoplasty procedure codes effective January 1, 2013.

Boston Scientific will participate in the healthcare conference on September 12. Learn how to watch the webcast or replay.

System is the world's first rechargeable SCS device; approval provides physicians with an additional diagnostic option for patients with chronic intractable pain.

World's first rechargeable SCS device approved for peripheral nerve stimulation for patients with chronic intractable pain of the trunk.

Newly revised European Society of Cardiology guidelines include LAA closure devices.